Quick Links
Resources
About MyLeukemiaTeam
Powered By
Below is a listing of treatments and therapies for leukemia. Click on one to read more information or connect with others currently using it.
Overview
6-mercaptopurine is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as a maintenance therapy for acute lymphocytic leukemia (ALL) and acute lymphoblastic leukemia. 6-mercaptopurine… read more
Overview
Stem cell transplant is sometimes used to treat people with leukemia. The majority of people with leukemia who undergo stem cell transplant receive an allogeneic stem cell transplant (allo-SCT), which means… read more
Overview
Arranon is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat T-cell acute lymphoblastic leukemia (ALL) and T-cell lymphoblastic lymphoma (T-LBL). Arranon is indicated in… read more
Overview
Arzerra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (SLL/CLL). Arzerra is often prescribed in combination with Cytoxan, Leukeran, or… read more
Overview
Asparlas is a prescription drug approved by the Food and Drug Administration (FDA) to treat children and young adults up to 21 years old with acute lymphoblastic leukemia (ALL). Asparlas is also referred to by… read more
Overview
Aucatzyl approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). To be eligible, a person must have…
Overview
Stem cell transplant is sometimes used to treat people with leukemia. The majority of people with leukemia who undergo stem cell transplant receive an allogeneic stem cell transplant, which means that the stem… read more
Overview
Besponsa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory cases of B-cell precursor acute lymphoblastic leukemia (ALL) in adults. Besponsa is also… read more
Overview
Blincyto is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory cases of B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children.… read more
Overview
Leukemia treatments including chemotherapy and radiation therapy can destroy bone marrow, making it impossible produce new blood cells. In people with some types of leukemia, cancer cells can damage the bone… read more
Overview
Bosulif is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic myelogenous leukemia (CML) that have tested positive for the Philadelphia chromosome (Ph+).… read more
Overview
Brukinsa is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Brukinsa is also referred to by its…
Overview
Busulfan is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic myelogenous leukemia (CML). Busulfan is often combined with other drugs such as Cytoxan and Fludara… read more
Overview
Calquence is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat people with mantle cell lymphoma (MCL) who have received at least one prior therapy. Calquence is sometimes… read more
Overview
Campath is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat B-cell chronic lymphocytic leukemia (B-CLL). Campath may also be prescribed off-label to treat B-cell… read more
Overview
Cerubidine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to induce remission in acute forms of leukemia such as acute lymphoblastic leukemia (ALL) and acute myeloid… read more
Overview
Chemotherapy is the treatment of cancer with drugs that destroy or slow the growth of cancer cells. Some doctors may refer to all medication prescribed for someone with leukemia as chemotherapy. Chemotherapy is… read more
Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for leukemia. Clinical trials are the only way that new treatments for leukemia can be tested.… read more
Overview
Clolar is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukemia (ALL) in children and young adults up to the age of 21. Clolar is indicated in… read more
Overview
According to the 2007 National Health Interview Survey, 65 percent of Americans who have ever been diagnosed with cancer have used non-traditional therapies. Complementary treatments are those used alongside… read more
Overview
Copiktra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma (FL) in adults.… read more
Overview
Corticosteroids are a class of prescription drugs approved by the Food and Drug Administration (FDA) to treat inflammation. Corticosteroids are sometimes used to treat people with leukemia.
The most common… read more
Overview
Cytarabine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating several types of leukemia including acute lymphocytic leukemia, acute myeloid leukemia, and chronic… read more
Overview
Cytoxan is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating cancers including acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic… read more
Overview
Dacogen is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with myelodysplastic syndromes (MDS). Dacogen is also referred to by its drug name, decitabine.
Dacogen… read more
Overview
Daurismo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat acute myeloid leukemia (AML) in people 75 or older and those who cannot undergo intensive chemotherapy. Daurismo… read more
Overview
Erwinaze is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukemia in individuals who are hypersensitive to asparaginase derived from E. coli.… read more
Overview
Regular physical activity has been shown to benefit people with leukemia in many ways. Exercise can improve the quality of life of those with leukemia during and after treatment. Being physically active helps… read more
Overview
People who currently have or have had leukemia and other cancers are at greater risk for severe infections and serious complications from influenza (the flu) and pneumonia.
The U.S. Centers for Disease… read more
Overview
Fludara is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with B-cell chronic lymphocytic leukemia (CLL). Fludara is often prescribed in combination with other… read more
Overview
Gazyva is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat previously untreated chronic lymphocytic leukemia (CLL) and certain types of follicular lymphoma. Gazyva is often… read more
Overview
Gleevec is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults and children with chronic myeloid leukemia (CML) that has tested positive for the Philadelphia chromosome… read more
Overview
Hydroxyurea is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic myeloid leukemia as well as specific types of squamous cell carcinomas in combination with… read more
Overview
Iclusig is a prescription drug approved by the Food and Drug Administration (FDA) to treat adults with chronic myelogenous leukemia (CML) in any phase that is positive for the Philadelphia chromosome (Ph+), in… read more
Overview
Idamycin is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute myeloid leukemia (AML) in adults. Idamycin is often combined with other drugs such as cytarabine in… read more
Overview
Idhifa is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory acute myeloid leukemia (AML) that has tested positive for a mutation in the isocitrate… read more
Overview
Imbruvica is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL) and several types of non-Hodgkin lymphoma. Imbruvica is also approved to… read more
Overview
In some cases of chronic lymphocytic leukemia (CLL), cancerous versions of white blood cells known as plasma B cells proliferate, crowding out normal cells. Healthy plasma cells secrete proteins called… read more
Overview
Jaypirca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma.… read more
Overview
Kymriah is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat B-cell precursor acute lymphoblastic leukemia (ALL) in people up to age 25. It is also approved for some types of… read more
Overview
In some types of leukemia – most often acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) – white blood cells are greatly overproduced, causing a condition known as hyperleukocytosis. In… read more
Overview
Leukeran is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, lymphosarcoma, and giant follicular lymphoma.… read more
Overview
Leustatin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with hairy cell leukemia. Leustatin is sometimes used off-label to treat acute myeloid leukemia (AML) and… read more
Overview
Lumoxiti is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory hairy cell leukemia. Lumoxiti is indicated in cases where two prior… read more
Overview
Marqibo is a prescription medication approved by the U.S. food and drug administration (FDA) used to treat adults with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL). Marqibo is… read more
Overview
Medical marijuana, also known as medical cannabis, is widely used to treat chronic pain, nausea, vomiting, loss of appetite, and insomnia, all common symptoms of leukemia or side effects of its treatment.… read more
Overview
Methotrexate is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some types of cancer, including acute lymphoblastic leukemia (ALL). Methotrexate is sold under brand names… read more
Overview
Mustargen is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL), chronic myelocytic leukemia (CML), mycosis fungoides, lymphosarcoma,… read more
Overview
Mylotarg is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat newly diagnosed adults with CD33 positive acute myeloid leukemia (AML) and adults and children with relapsed or… read more
Overview
Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections for people with certain types of cancer after receiving chemotherapy or some types… read more
Overview
Nipent is a prescription medication approved by the U.S.Food and Drug Administration (FDA) to treat hairy cell leukemia in people with active disease. This drug is indicated in individuals with new hairy cell… read more
Overview
Novantrone is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat acute nonlymphocytic leukemia (ANLL) in adults. Novantrone is also known by its drug name, mitoxantrone. The… read more
Overview
Everyone feels their best when they consistently eat a healthy, balanced diet. For people with leukemia, good nutrition can help you recover from treatment, reduce treatment side effects, support bone health,… read more
Overview
Oncaspar is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukemia (ALL). Oncaspar is often used as a part of a chemotherapy regimen. Oncaspar… read more
Overview
Onureg is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute myeloid leukemia who achieved a first complete remission or complete remission with… read more
Overview
Radiation therapy (also called RT or radiotherapy) is not commonly used to treat leukemia. However, radiation therapy is used in some cases of acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia… read more
Overview
Revuforj is approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory acute leukemia in adults and children aged 1 year and older with a lysine methyltransferase 2A gene…
Overview
Rituxan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL) and several types of non-Hodgkin lymphoma in adults. It is also indicated for… read more
Overview
Rituxan Hycela is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia and some types of lymphoma. Rituxan Hycela is usually prescribed together with… read more
Overview
Rydapt is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute myelogenous leukemia (AML) that has tested positive for the FLT3 mutation. Rydapt is also… read more
Overview
Scemblix is approved by the U.S. Food and Drug Administration (FDA) to treat adults with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia, or Ph+ CML, in its early stages…
Overview
Splenectomy is the surgical removal of the spleen, a small organ located on the left side of your abdomen, under the rib cage. A healthy spleen filters old or abnormal red blood cells out of the blood and… read more
Overview
Sprycel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic myeloid leukemia (CML) in the chronic phase who have tested positive for the Philadelphia… read more
Overview
Synribo is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic myeloid leukemia (CML) in the chronic or accelerated phase. Synribo is indicated in… read more
Overview
Tasigna is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 1 year or older newly diagnosed with chronic myelogenous leukemia (CML) in the chronic… read more
Overview
Thioguanine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute nonlymphocytic leukemias. Thioguanine is often combined with other medications in a chemotherapy… read more
Overview
Tibsovo is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory acute myeloid leukemia (AML) that has tested positive for a mutation in… read more
Overview
Treanda, also known by its drug name, bendamustine, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL) and indolent B-cell… read more
Overview
Trisenox is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating acute promyelocytic leukemia (APL) unresponsive to other forms of chemotherapy. Trisenox is reserved… read more
Overview
Vanflyta is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) that is FLT3 internal tandem duplication (ITD)-positive. This drug…
Overview
Venclexta is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Venclexta is also… read more
Overview
Vincristine sulfate is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat several types of leukemia, including acute lymphoblastic leukemia (ALL). Vincristine sulfate is… read more
Overview
Vyxeos is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute myeloid leukemia (AML) that developed after treatment for another type of cancer, known as… read more
Overview
Xospata is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory acute myelogenous leukemia (AML) that has tested positive for the FLT3… read more
Overview
Zydelig is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed cases of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular B-cell… read more
Sign up for free!
Continue with Facebook
Sign up with your email
